Relmada Therapeutics Filing Effectiveness Noted
Ticker: RLMD · Form: EFFECT · Filed: Apr 10, 2026 · CIK: 0001553643
| Field | Detail |
|---|---|
| Company | Relmada Therapeutics, Inc. (RLMD) |
| Form Type | EFFECT |
| Filed Date | Apr 10, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: registration-statement, effectiveness, filing-update
TL;DR
Relmada's registration statement is now effective as of 4/9/2026.
AI Summary
Relmada Therapeutics, Inc. filed an EFFECT form on April 10, 2026, indicating the effectiveness of a registration statement. The filing, with SEC Accession No. 9999999995-26-001136, relates to Act 33 and File No. 333-294885. The effectiveness date was April 9, 2026.
Why It Matters
This filing signifies that a registration statement for Relmada Therapeutics, Inc. has become effective, which is a crucial step for certain securities offerings or corporate actions.
Risk Assessment
Risk Level: low — This is a routine administrative filing indicating the effectiveness of a registration statement, not a material event like an acquisition or earnings miss.
Key Numbers
- 2026-04-09 — Effectiveness Date (The date the registration statement became effective.)
- 2026-04-10 — Filing Date (The date the filing was accepted by the SEC.)
Key Players & Entities
- Relmada Therapeutics, Inc. (company) — Filer
- 9999999995-26-001136 (dollar_amount) — SEC Accession Number
- 2026-04-10 (dollar_amount) — Filing Acceptance Date
- 2026-04-09 (dollar_amount) — Effectiveness Date
- 333-294885 (dollar_amount) — File Number
FAQ
What type of filing is this?
This is an EFFECT filing, which indicates the effectiveness of a registration statement.
Who is the filer?
The filer is Relmada Therapeutics, Inc. (CIK: 0001553643).
When did the registration statement become effective?
The registration statement became effective on April 9, 2026.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 9999999995-26-001136.
What is the File Number associated with this filing?
The File Number is 333-294885.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 10, 2026 regarding RELMADA THERAPEUTICS, INC. (RLMD).